Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amjad M. Alotaibi"'
Autor:
Areej S. Albahdal, Amjad M. Alotaibi, Miteb A. Alanazi, Norah Abanmy, Monira Alwhaibi, Yazed AlRuthia
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background The study aimed to examine the direct medical cost and impact of tocilizumab (TOZ) versus adalimumab (ADM) and etanercept (ETC) on reducing the levels of two inflammatory markers (e.g., C-reactive protein (CRP) and erythrocyte sed
Externí odkaz:
https://doaj.org/article/c18466bafb4b4e77b3c39bbbd050098f
Autor:
Amjad M. Alotaibi, Areej S. Albahdal, Norah Abanmy, Monira Alwhaibi, Yousif Asiri, Yazed AlRuthia
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Purpose: The aim of this study was to assess the quality of life (QOL) of patients with rheumatoid arthritis (RA) on tocilizumab versus other commonly used monoclonal antibodies (mAbs) (e.g., adalimumab and etanercept).Methods: This was an interview-
Externí odkaz:
https://doaj.org/article/6fa15cd128074e9790335a56deaeac84